Overlooked in the tax debate are small-business owners who pay through personal income taxes. Still, a solution for dwindling corporate tax income is elusive. More
AGN
Recent Articles
3 Reasons Why Alexion Is the Real Deal
Alexion's fundamentals and strength in a narrow category of drugs called biopharmaceuticals make ALXN a promising stock. More
10 Big Pharma Stocks to Buy
Pharmaceutical stocks and drugmakers are theoretically recession-proof businesses. Still, not all pharma companies are created equal. Here are 10 clear winners More
New CEO Tasked with Getting Hospira Back on Track
Priorities for Hospira's new CEO include fixing manufacturing problems, launching biosimilars in the U.S. More
